-
1
المؤلفون: Annick de Vries, Henk-Jan Guchelaar, Sandra M. Arend, David J. van Westerloo, Judith van Paassen, Dirk Jan A.R. Moes, Simone A. Joosten, Mark G. J. de Boer, Jesse J. Swen, Teun van Gelder
المصدر: Clinical Pharmacokinetics, 61, 231-247. ADIS INT LTD
Clinical Pharmacokineticsمصطلحات موضوعية: Adult, Population, Antibodies, Monoclonal, Humanized, law.invention, chemistry.chemical_compound, Tocilizumab, Randomized controlled trial, Pharmacokinetics, law, Humans, Medicine, Pharmacology (medical), Original Research Article, Dosing, education, Pharmacology, Volume of distribution, education.field_of_study, SARS-CoV-2, business.industry, Intensive care unit, COVID-19 Drug Treatment, Intensive Care Units, chemistry, Anesthesia, Pharmacodynamics, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ea4c2d9d2e79075e5417172e80535e
http://hdl.handle.net/1887/3247609 -
2
المؤلفون: Mark G. J. de Boer, Henk-Jan Guchelaar, Dirk Jan A.R. Moes, Teun van Gelder, Sandra M. Arend, Judith van Paassen, Simone A. Joosten, Annick de Vries, David J. van Westerloo, Jesse J. Swen
مصطلحات موضوعية: Mechanical ventilation, medicine.medical_specialty, education.field_of_study, business.industry, medicine.medical_treatment, Population, Intensive care unit, law.invention, chemistry.chemical_compound, Regimen, Tocilizumab, chemistry, Randomized controlled trial, Pharmacokinetics, Informed consent, law, Internal medicine, Pharmacodynamics, Anesthesia, Concomitant Therapy, Medicine, Dosing, education, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83c76f216138f4aebce0834c84603188
https://doi.org/10.1101/2021.05.10.21256933 -
3
المؤلفون: Jan Jelrik Oosterheert, Peter M. Schneeberger, Mark G J de Boer, S.D. Marbus, Jutte J.C. de Vries, Noor Ismail, Geert H. Groeneveld, Jaap T. van Dissel
المصدر: International Journal of Antimicrobial Agents, 56(5). ELSEVIER
مصطلحات موضوعية: Male, 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Oseltamivir, Complications, 030106 microbiology, Neuraminidase, Comorbidity, Disease, Antiviral Agents, Virus, law.invention, Seasonal influenza, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, law, Internal medicine, Influenza, Human, Humans, Medicine, Pharmacology (medical), Hospital Mortality, 030212 general & internal medicine, Mortality, Propensity Score, Aged, Netherlands, Retrospective Studies, business.industry, Mortality rate, virus diseases, Retrospective cohort study, General Medicine, Length of Stay, Middle Aged, Intensive care unit, Influenza, Treatment, Treatment Outcome, Infectious Diseases, chemistry, 30 day mortality, Female, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c681fe50754ea3213254a880dbb3e094
http://hdl.handle.net/10029/624384 -
4
المؤلفون: Mark G. J. de Boer, Alma B Pedersen, Christina M. J. E. Vandenbroucke-Grauls, Camilla Skaarup Jensen, Josefine Aalestrup, Sarah Melissa Nørgaard
المصدر: Antimicrobial Resistance and Infection Control
Nørgaard, S M, Jensen, C S, Aalestrup, J, Vandenbroucke-Grauls, C M J E, De Boer, M G J & Pedersen, A B 2019, ' Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens : A systematic review ', Antimicrobial resistance and infection control, vol. 8, no. 1, 170 . https://doi.org/10.1186/s13756-019-0624-1
Antimicrobial Resistance and Infection Control, 8(1)
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-13 (2019)مصطلحات موضوعية: Microbiology (medical), Imipenem, medicine.medical_specialty, medicine.drug_class, Clinical Decision-Making, Antibiotics, Microbial Sensitivity Tests, Drug resistance, Review, Meropenem, beta-Lactamases, lcsh:Infectious and parasitic diseases, chemistry.chemical_compound, Antibiotic resistance, Enterobacteriaceae, Drug Resistance, Multiple, Bacterial, Internal medicine, Gram-Negative Bacteria, medicine, polycyclic compounds, Humans, lcsh:RC109-216, Pharmacology (medical), baumannii, business.industry, MDR bacteria, Public Health, Environmental and Occupational Health, Disease Management, biochemical phenomena, metabolism, and nutrition, Prognosis, bacterial infections and mycoses, aeruginosa, Anti-Bacterial Agents, Treatment, Treatment Outcome, Infectious Diseases, P. aeruginosa, chemistry, Doripenem, Colistin, bacteria, Gram-Negative Bacterial Infections, business, A. baumannii, Publication Bias, Ertapenem, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaede655dbf6ad6e9b867652821674cc
https://hdl.handle.net/1887/120704 -
5
المصدر: Open Forum Infectious Diseases
مصطلحات موضوعية: Resistance (ecology), business.industry, Triazole, Computational biology, Aspergillosis, medicine.disease, Abstracts, chemistry.chemical_compound, Infectious Diseases, Oncology, chemistry, A. Oral Abstracts, Medicine, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be5deb993d27bce52cfadb5186f8a76
https://doi.org/10.1093/ofid/ofy209.084 -
6
المؤلفون: Guido E.L. van den Berk, Mark G. J. de Boer, Willemien Dorama, Kees Brinkman, Daoud Ait Moha, Natasja van Holten, Josephine E. Oryszcyn
المصدر: AIDS, 30(18), 2831-2834
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Pyridones, 030106 microbiology, Immunology, HIV Infections, Piperazines, Medication Adherence, Cohort Studies, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Abacavir, Antiretroviral Therapy, Highly Active, Internal medicine, Oxazines, Product Surveillance, Postmarketing, Humans, Immunology and Allergy, Medicine, 030212 general & internal medicine, Aged, Netherlands, Aged, 80 and over, Sleep disorder, business.industry, integrase inhibitor, toxicity, Middle Aged, medicine.disease, Confidence interval, Discontinuation, dolutegravir, Regimen, side effects, Infectious Diseases, Anti-Retroviral Agents, Withholding Treatment, chemistry, Relative risk, Dolutegravir, Female, business, Heterocyclic Compounds, 3-Ring, Cohort study, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7afd65f94cd40c4f10ec82a622eb1177
https://hdl.handle.net/1887/112105